Table 1.
Group A | Group B | P value | |
---|---|---|---|
Gender (male: female) | 28: 13 | 27: 9 | 0.516* |
Age (years) | 49.2 ± 12.9 | 47.4 ± 11.6 | 0.535† |
≤ 50 (number) | 21 | 19 | 0.891* |
> 50 (number) | 20 | 17 | |
Contralateral eyes with BCVA <20/200 (number) | 16 | 5 | 0.013* |
Disease course (days) | 15.0 ± 8.7 | 11.94 ± 7.2 | 0.098† |
Follow-up duration (months) | 12.9 ± 4.5 | 13.6 ± 4.7 | 0.473† |
Preoperative logMAR BCVA (Snellen equivalent) | 1.22 ± 0.64 (20/332) | 1.12 ± 0.58 (20/264) | 0.496† |
Range of RD (clock hours) | 4.7 ± 1.5 | 4.6 ± 1.3 | 0.707† |
Macula (on: off) | 23: 18 | 22: 14 | 0.656* |
Superior retinal breaks | |||
Number | 1.9 ± 1.0 | 2.1 ± 1.0 | 0.359‡ |
Total area (PD) | 2.1 ± 1.0 | 2.2 ± 1.0 | 0.646† |
Lens status (phakic: pseudophakic) | 35: 6 | 31: 5 | 0.926* |
Presence of Inferior retinal breaks (yes: no) | 11: 30 | 10: 26 | 0.926* |
BCVA best corrected visual acuity, logMAR logarithm of minimal angle of resolution, RD retinal detachment, PD papilla diameter
Statistical analysis: * = χ2 analysis; † = unpaired t test; ‡ = unpaired Mann-Whitney test
Continuous values presented as mean ± standard deviation,